PEAR’s Substance Use Disorder therapy, reSETTM, featured in Neurotech Insights

Pear Therapeutics Advances the First Regulated Digital Therapies for Addiction

Pear Therapeutics has grown significantly over the past year and now boasts forty employees split between the Boston, MA office and the San Francisco, CA location. NeuroInsights caught up with Dr. Corey McCann, founder and CEO, to learn about Pear’s progress developing digital therapeutics.